<code id='70E5306F16'></code><style id='70E5306F16'></style>

<acronym id='70E5306F16'></acronym>

<center id='70E5306F16'><center id='70E5306F16'><tfoot id='70E5306F16'></tfoot></center><abbr id='70E5306F16'><dir id='70E5306F16'><tfoot id='70E5306F16'></tfoot><noframes id='70E5306F16'>

<optgroup id='70E5306F16'><strike id='70E5306F16'><sup id='70E5306F16'></sup></strike><code id='70E5306F16'></code></optgroup>

<b id='70E5306F16'><label id='70E5306F16'><select id='70E5306F16'><dt id='70E5306F16'><span id='70E5306F16'></span></dt></select></label></b><u id='70E5306F16'></u>

~~<i id='70E5306F16'><strike id='70E5306F16'><tt id='70E5306F16'><pre id='70E5306F16'></pre></tt></strike></i>~~

Home» comprehensive» hotspot

hotspot

hotspot

author：leisure time 2025-09-27 14:32:50 Page View：86989

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

advertisement

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Helping hospitals and community health centers plan for resilience
Next article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

Trump demands the U.S. pay no more for drugs than other countries … again

EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

John-ArneRøttingenistheheadoftheWellcomeTrust,oneoftheworld’stopprivatefundersofbiomedicalresearch.I

In Memoriam: Notable people who died in 2023

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

Celiac disease study examines precisely how gluten triggers injury

AmicrographofCeliacdiseaseNephron/WikimediaCommonsForapersonwithceliacdisease,eatingabagelgoessometh

read more